Kobayashi Pharmaceutical Company Ltd (PK) KBYPF Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
Kobayashi Pharmaceutical Company Ltd (PK) (KBYPF)
Kobayashi Pharmaceutical Company Ltd (PK) (KBYPF) Financials

Kobayashi Pharmaceutical Company Ltd (PK) (KBYPF)

37.43

0.00

(0.00%)

Closed November 26 3:00PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)
Total Revenue	120.05B	156.76B	167.48B	168.05B	150.51B	155.25B	166.26B	173.46B
Operating Income	16.07B	21.98B	24.33B	24.7B	24.82B	25.76B	26.6B	25.72B
Pre Tax Income	19.8B	22.57B	25.3B	26.8B	26.64B	27.64B	27.95B	27.56B
Net Income	14.32B	15.86B	18.02B	19.14B	19.21B	19.72B	20.02B	20.34B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	168.383	193.333	219.659	233.26	234.065	240.28	256.528	260.577
EBIT	15.08B	20.1B	23.14B	23.93B	24.27B	25.18B	26.05B	26.8B
EBITDA	20.04B	27.04B	29.69B	30.48B	30.05B	30.9B	32.03B	31.84B

Kobayashi Pharmaceutical (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions